Artificial Intelligence and Machine Learning for Safe Medicines. | Drug Saf;45(5): 403-405, 2022 05. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Artificial Intelligence and Machine Learning for Safe Medicines.

Bate, Andrew; Luo, Yuan.

Bate A; GSK, Brentford, UK. andrew.x.bate@gsk.com.
Luo Y; LSHTM, London, UK. andrew.x.bate@gsk.com.

Drug Saf ; 45(5): 403-405, 2022 05.

Article in English | MEDLINE | ID: covidwho-1872803

ABSTRACT

ABSTRACT

Authors' views on the role of artificial intelligence and machine learning in pharmacovigilance. (MP4 139807 kb).

Subject(s)

Artificial Intelligence; Machine Learning; Humans; Pharmacovigilance

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Artificial Intelligence / Machine Learning Limits: Humans Language: English Journal: Drug Saf Journal subject: Drug Therapy / Toxicology Year: 2022 Document Type: Article Affiliation country: S40264-022-01177-0

Similar

MEDLINE

LILACS

LIS

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Artificial Intelligence / Machine Learning Limits: Humans Language: English Journal: Drug Saf Journal subject: Drug Therapy / Toxicology Year: 2022 Document Type: Article Affiliation country: S40264-022-01177-0